{
  "id": "adv_mhgap#risk_safety_c920ce5e",
  "content": "In selecting the appropriate essential medication,\nuntil the symptoms begin to respond to treatment.\nconsider the side effect profile of the medication (short – Document key aspects of interactions with the person\nOnce symptoms start improving, schedule less frequent\nand long term), efficacy of past treatment, drug-drug and the family in the case notes.\nbut regular appointments.\ninteractions or drug-disease interactions.\nRefer to the management section of relevant\nConsult the National Formulary or the WHO Formulary as\nAt each follow-up meeting, assess for:\nmodule(s) for disorder-specific follow-up information.\nneeded.\n– Response to treatment, medication side-effects, and ad-\nEducate the person about risks and benefits of treatment, herence to medications and psychosocial interventions.\npotential side effects, duration of treatment, and impor- – General health status (be sure to monitor physical health\ntance of adherence. status regularly).\nExercise caution when providing medication to special – Self-care (e.g. diet, hygiene, clothing) and functioning in\ngroups such as older people, those with chronic disease, the person’s own environment.\nwomen who are pregnant or breastfeeding, and children/\n– Psychosocial issues and/or change in living conditions\nadolescents. Consult a specialist as needed.\nthat can affect management.\n– The person’s and the carer’s understanding and expec-",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "relationships",
      "coping_skill",
      "habits",
      "risk_safety",
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Risk Safety In selecting the appropriate essential medication,\nuntil the symptoms begin to respond to treatment.\nconsider the side effect profile of the medication (short – Document key aspects of interactions with the person\nOnce symptoms start improving, schedule less frequent\nand long term), efficacy of past treatment, drug-drug and the family in the case notes.\nbut regular appointments.\ninteractions or drug-disease interactions.\nRefer to the management section of relevant\nConsult the National Formulary or the WHO Formulary as\nAt each follow-up meeting, assess for:\nmodule(s) for disorder-specific follow-up information.\nneeded.\n– Response to treatment, medication side-effects, and ad-\nEducate the person about risks and benefits of treatment, herence to medications and psychosocial interventions.\npotential side effects, duration of treatment, and impor- – General health status (be sure to monitor physical health\ntance of adherence. status regularly).\nExercise caution when providing medication to special – Self-care (e.g. diet, hygiene, clothing) and functioning in\ngroups such as older people, those with chronic disease, the person’s own environment.\nwomen who are pregnant or breastfeeding, and children/\n– Psychosocial issues and/or change in living conditions\nadolescents. Consult a specialist as needed.\nthat can affect management.\n– The person’s and the carer’s understanding and expec- In selecting the appropriate essential medication,\nuntil the symptoms begin to respond to treatment. consider the side effect profile of the medication (short – document key aspects of interactions with the person\nonce s..."
}